Common core variables for childhood cancer data integration by Daniela Di Carlo, Ruth Ladenstein, Norbert Graf, Johannes Hans Merks, Gustavo Hernández-Peñaloza, Pamela Kearns, Gianni Bisogno

Get full text

Changing incentives to ACCELERATE drug development for paediatric cancer by Teresa deRojas, Pamela Kearns, Patricia Blanc, Jeffrey Skolnik, Elizabeth Fox, Leona Knox, Raphael Rousseau, François Doz, Nick Bird, Andrew J. Pearson, Gilles Vassal

Get full text

Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study proto... by Sarah Johnson, Geoff Shenton, Ruth Plummer, Joshua Savage, Gareth J Veal, Julie Irving, Lucinda Billingham, Pamela Kearns, Daniel Slade, Tobias Menne, Britta Vormoor, Josef Vormoor

Get full text

Hodgkin/Reed-Sternberg cells induce GPNMB expression and release from macrophages to suppress T-cell responses to the Epstein-Barr virus-encoded LMP2A protein by Navta Masand, Tracey A. Perry, Matthew Pugh, Eanna Fennell, Aoife Hennessy, Wenbin Wei, Katerina Bouchalova, David Burns, Pamela Kearns, Graham Taylor, Katerina Vrzalikova, Paul G. Murray

Get full text

Meeting report of the 1st SIOP Europe Course in Paediatric Oncology: Maasmechelen, Belgium, April 6–9, 2022 – The participants’ view and experience by Raphael J. Morscher, Sarah Al-Jilaihawi, Johan Hamrin, Fiona Poyer, Raheel Altaf Raja, Annika V. Rademacher, Anne Blondeel, Samira Essiaf, Pamela Kearns, Carmelo Rizzari, Reineke Schoot, Andishe Attarbaschi

Get full text

CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults by Dhruv Parekh, Simon Gates, Julian Bion, Tonny Veenith, Matthew Rowland, Tony Whitehouse, Anna Rowe, Pamela Kearns, Benjamin A. Fisher, Daniel Slade, Rowena Sharpe, David R. Thickett, James Scriven, Sarah J. Bowden, Joshua S. Savage, Duncan Richards

Get full text